reviewGutOct 13, 2011Closed access

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

Beaumont Hospital, Royal Oak · Royal Oak Community Coalition · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Introduction

The risk of oesophageal adenocarcinoma (OAC) in non-dysplastic Barrett's oesophagus (BO) may have been overestimated. The objective was to estimate the incidence of OAC in patients with BO without dysplasia.

Methods

The authors searched MEDLINE and EMBASE from 1966 to 2011 and performed a bibliographic review of previous publications, excluding abstracts, non-peer-reviewed publications and those not published in English, for prospective or retrospective studies of the incidence of OAC in patients with BO. They excluded patients with any degree of dysplasia at baseline and those without documented intestinal metaplasia. Studies were independently reviewed by two individuals. 57 of 3450 studies were included. The authors extracted information on number of patients with BO, length of follow-up, incident cases of OAC, mean age of patients, country of origin, whether prospective or retrospective, mean length of BO segments and mortality from causes other than OAC. Study quality was assessed by the Ottawa Newcastle criteria.

Citation impact

610
total citations
FWCI
31.71
Percentile
100%
References
118
Citations per year

Authors

7

Topics & keywords

Keywords
  • Medicine
  • Incidence (geometry)
  • Dysplasia
  • Intestinal metaplasia
  • Internal medicine
  • Barrett's esophagus
  • Gastroenterology
  • Retrospective cohort study
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.